Total Payments
$6,353
2024 Payments
$966.52
Companies
33
Transactions
83
Medicare Patients
627
Medicare Billing
$8.9M
Payment Breakdown by Category
Food & Beverage$5,130 (80.8%)
Travel$1,223 (19.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,130 | 79 | 80.8% |
| Travel and Lodging | $1,223 | 4 | 19.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $1,319 | 5 | $0 (2017) |
| Abbott Laboratories | $752.04 | 11 | $0 (2024) |
| Nuvectra Corporation | $498.32 | 4 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $485.95 | 4 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $365.01 | 3 | $0 (2019) |
| Amgen Inc. | $352.23 | 3 | $0 (2019) |
| Horizon Therapeutics plc | $268.04 | 2 | $0 (2020) |
| Medtronic, Inc. | $267.22 | 1 | $0 (2021) |
| SPR Therapeutics, Inc | $260.99 | 12 | $0 (2024) |
| Akcea Therapeutics, Inc. | $250.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $966.52 | 28 | SPR Therapeutics, Inc ($260.99) |
| 2023 | $122.10 | 1 | Alexion Pharmaceuticals, Inc. ($122.10) |
| 2022 | $119.27 | 1 | Alexion Pharmaceuticals, Inc. ($119.27) |
| 2021 | $267.22 | 1 | Medtronic, Inc. ($267.22) |
| 2020 | $124.99 | 1 | Horizon Therapeutics plc ($124.99) |
| 2019 | $1,281 | 10 | Akcea Therapeutics, Inc. ($250.00) |
| 2018 | $1,392 | 18 | Abbott Laboratories ($429.10) |
| 2017 | $2,080 | 23 | BOSTON SCIENTIFIC CORPORATION ($1,319) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: Pain management | ||||||
| 12/17/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $115.06 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $5.88 | General |
| Category: Pain management | ||||||
| 12/10/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $3.19 | General |
| Category: Pain management | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $118.57 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $71.20 | General |
| Category: Pain management | ||||||
| 11/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Analgesic | ||||||
| 11/08/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $3.83 | General |
| Category: Pain management | ||||||
| 11/06/2024 | LENOSS MEDICAL INC | Access & Cavity Creation Kit (Device) | Food and Beverage | In-kind items and services | $99.45 | General |
| Category: Surgical | ||||||
| 10/29/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $6.81 | General |
| Category: Pain management | ||||||
| 10/29/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $1.32 | General |
| Category: Pain management | ||||||
| 10/22/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Pain management | ||||||
| 10/18/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 10/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $5.58 | General |
| Category: Pain management | ||||||
| 10/08/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $1.24 | General |
| Category: Pain management | ||||||
| 09/05/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $13.43 | General |
| 08/29/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $105.20 | General |
| Category: Pain management | ||||||
| 08/29/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Pain management | ||||||
| 08/15/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Analgesic | ||||||
| 08/12/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.42 | General |
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/30/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: OSTEOARTHRITIS | ||||||
| 05/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 17 | 496 | 71,516 | $15.6M | $4.4M |
| 2021 | 4 | 119 | 17,954 | $17.3M | $4.5M |
| 2020 | 1 | 12 | 53 | $57,016 | $7,340 |
Total Patients
627
Total Services
89,523
Medicare Billing
$8.9M
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3241 | Injection, teprotumumab-trbw, 10 mg | Office | 2022 | 20 | 13,762 | $11.7M | $3.2M | 27.3% |
| J3490 | Unclassified drugs | Office | 2022 | 15 | 2,875 | $985,294 | $510,789 | 51.8% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 12 | 13,200 | $905,302 | $229,711 | 25.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 21 | 20,160 | $711,739 | $153,085 | 21.5% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2022 | 27 | 9,656 | $173,583 | $90,114 | 51.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 13 | 2,960 | $348,732 | $83,048 | 23.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 47 | 3,541 | $252,899 | $60,523 | 23.9% |
| J3358 | Ustekinumab, for intravenous injection, 1 mg | Office | 2022 | 11 | 4,160 | $143,612 | $31,066 | 21.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 56 | 200 | $156,755 | $26,516 | 16.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 72 | 244 | $56,978 | $16,151 | 28.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 115 | 336 | $32,466 | $4,485 | 13.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 22 | 124 | $37,845 | $3,496 | 9.2% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 11 | 94 | $10,884 | $1,907 | 17.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 15 | 79 | $7,069 | $1,238 | 17.5% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 12 | 16 | $3,380 | $619.09 | 18.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 13 | 65 | $18,368 | $331.36 | 1.8% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 14 | 44 | $587.74 | $206.00 | 35.0% |
| J3241 | Injection, teprotumumab-trbw, 10 mg | Office | 2021 | 23 | 17,599 | $17.0M | $4.4M | 26.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 45 | 194 | $188,000 | $27,790 | 14.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 24 | 63 | $21,000 | $4,577 | 21.8% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 27 | 98 | $35,050 | $2,986 | 8.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 12 | 53 | $57,016 | $7,340 | 12.9% |
About Dr. Vikram Sengupta, MD
Dr. Vikram Sengupta, MD is a Interventional Pain Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1740568153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Sengupta, MD has received a total of $6,353 in payments from pharmaceutical and medical device companies, with $966.52 received in 2024. These payments were reported across 83 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,130).
As a Medicare-enrolled provider, Sengupta has provided services to 627 Medicare beneficiaries, totaling 89,523 services with total Medicare billing of $8.9M. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Manhasset, NY
- Active Since 08/02/2011
- Last Updated 12/04/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740568153
Products in Payments
- PRECISION (Device) $1,187
- Algovita (Device) $498.32
- SCS IPGs (Device) $456.20
- STELARA (Biological) $365.01
- Aimovig (Biological) $352.23
- Simulus (Device) $267.22
- SPRINT PNS System (Device) $260.99
- TEGSEDI (Drug) $250.00
- Prometra II (Device) $146.03
- KRYSTEXXA (Biological) $143.05
- SPRAVATO (Drug) $140.67
- S-Series SCS Leads (Device) $140.38
- Cimzia (Drug) $134.15
- GENERAL - PAIN MANAGEMENT (Device) $132.00
- SOLIRIS (Drug) $125.00
- TEPEZZA (Drug) $124.99
- TYSABRI (Biological) $124.99
- QULIPTA (Drug) $124.85
- SOLIRIS (Biological) $122.10
- ULTOMIRIS (Biological) $119.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.